ADHD diagnoses soared amid 20-year drug marketing campaign

After more than 50 years leading the fight to legitimize attention deficit hyperactivity disorder, Keith Conners could be celebrating.

Read More: ADHD diagnoses soared amid 20-year drug marketing campaign

Rep. Tim Murphy Introduces Mental-Health Legislation

Rep. Tim Murphy (R., Pa.), the chairman of the House Energy and Commerce subcommittee on Oversight and Investigation, introduced a wide-ranging mental health care bill that would change the way mental illness is treated.

Rep. Tim Murphy Introduces Mental-Health Legislation

‘Daily Show’ Takes on Johnson & Johnson’s Criminal Allegations

Jon Stewart takes on pharmaceutical giant Johnson & Johnson, saying the criminal allegations against the company are far worse than the shootings, decapitations and massacres encountered in the popular video game Grand Theft Auto.

‘Daily Show’ Takes on Johnson & Johnson’s Criminal Allegations

Drug Firm Pays Billions for Misbranding Antipsychotics

Johnson & Johnson was sued for failing to report data suggesting increased risks for stroke and diabetes associated with the antipsychotic Risperdal.

Read More >> Drug Firm Pays Billions for Misbranding Antipsychotics

CCHR hits psychiatrists for turning classrooms into ADHD labs

The Citizens Commission on Human Rights (CCHR) is working diligently to eradicate mental health abuses
while enacting patient and consumer protections from what psychiatrists push on people. Mental health abuses are an international problem. Brian Daniels, who is the National Spokesperson for the CCHR in the United Kingdom, has written for CCHR International on Dec. 2, 2013, that school classrooms are being turned into labs for ADHD diagnoses and the drugging of kids.

Read More >> CCHR hits psychiatrists for turning classrooms into ADHD labs

Psychiatric Drug Therapy Among U.S. Teenagers Levels Off at 6%

About 6 percent of U.S. teenagers report using a psychiatric medicine, such as an antidepressant or attention-deficit treatment, as drug therapy for the conditions remains steady, a government survey found.


Read more >> Psychiatric Drug Therapy Among U.S. Teenagers Levels Off at 6%

Psychostimulant and non-stimulant agents address the symptoms of ADHD, substantial evidence shows.

ADHD, the most common childhood neurobehavioral disorder, is characterized by difficulties with attention, impulse control, and modulating activity level. The pathophysiology of ADHD is thought to involve dysregulation of brain dopamine and norepinephrine systems.1 Managing ADHD includes pharmacotherapeutic and nonpharmacotherapeutic—ie, behavioral and psychoeducational—interventions.2,3

Psychostimulant and non-stimulant agents address the symptoms of ADHD, substantial evidence shows.

They act as if that is a good thing.